OAM
NNVC icon

Oxford Asset Management’s NanoViricides NNVC Stock Holding History

Oxford Asset Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,561
Closed -$50K – 822
2016
Q2 		$50K Buy
+1,561
New +$56.9K ﹤0.01% 755

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
PTB
Pioneer Trust Bank Salem, Oregon $412M AUM 17.77% 1-Year Est. Return

Oxford Asset Management's NNVC Position: Q3 2016 in Review

Oxford Asset Management sold out of NanoViricides (NNVC) in Q3 2016, closing a stake of 1,561 shares — an estimated $50K sold.

Oxford Asset Management first reported a position in NNVC in Q2 2016 and held it in 1 quarter. The position peaked at $50K in Q2 2016. 41 funds tracked by Wall St. Rank hold NNVC as of Q3 2016.

  • Oxford Asset Management reported no remaining NanoViricides position as of Q3 2016 after selling out during the quarter.
  • Oxford Asset Management sold 1,561 NanoViricides shares in Q3 2016, an estimated $50K.
  • Oxford Asset Management first reported a position in NanoViricides in Q2 2016 and held it in 1 quarter.
  • Oxford Asset Management's NanoViricides position peaked at $50K in Q2 2016.
  • 41 funds tracked by Wall St. Rank held NanoViricides as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.